THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY by S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich

Subjects: Get full text

Exploring community pharmacists’ knowledge, perception and experiences towards branded and generic medicines in Kuwait: Highlighting the role of pharmacist by M. Al Hussaini, N. Alsaffar, A. Abdulraheem

Subjects: “…Generic drug…”
Get full text

Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment by G. V. Ramenskaya, I. E. Shokhin, N. I. Gaponova, V. R. Abdrakhmanov

Subjects: Get full text

Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd. by Makoto Kosaka, Akihiko Ozaki, Yudai Kaneda, Hiroaki Saito, Erika Yamashita, Anju Murayama, Hanano Mamada, Tetsuya Tanimoto, Mihajlo Jakovljevic

Get full text

Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs by Ping Ren, Theresa Chan, Wen-Cheng Yang, Mitchell Frost, Yan Wang, Markham Luke, Myong-Jin Kim, Robert Lionberger, Yi Zhang

Get full text

Mitigating the Risks of Generic Drug Product Development: An Application of Quality by Design (QbD) and Question based Review (QbR) Approaches. by Manjurul Kader

“…This paper discusses the challenges and advantages of implementing Quality by Design (QbD) and Question based Review (QbR) when developing solid dosage formulations and manufacturing processes for generic drugs. Formulation and process development of a drug product is challenging due to the inherent variability of the processes. …”
Get full text

Representações sociais do medicamento genérico por farmacêuticos: determinação dos sistemas central e periférico by Maria Cleide Ribeiro Dantas de Carvalho, Horácio Accioly Jr., Fernanda Nervo Raffin, Mariana Nunes Campos, Marcelle Marie Caldas Cruz, Markênia Kélia Santos Alves

Subjects: “…generic drugs…”
Get full text

THE POSPONT RESULTS OF SWITCHING ON TOPIRAMAT GENERICS AT PATIENTS WITH EPILEPSY by I. G. Rudakova

Subjects: Get full text

The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis by Heather C. Worthington, Lucy Cheng, Sumit R. Majumdar, Steven G. Morgan, Colette B. Raymond, Stephen B. Soumerai, Michael R. Law

Subjects: Get full text

Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners by Virgil Beauvais, Annabelle Marque, Guillaume Ferté, Jan Chrusciel, Julie Souille, Pierre Nazeyrollas, Stéphane Sanchez

Subjects: “…Generic drugs…”
Get full text

Analiza nawyków i zachowań związanych ze stosowaniem leków oryginalnych i generycznych = The analysis of behaviour related to the use of original and generic drugs by Piotr Kozłowski, Dominika Streit, Magdalena Kozłowska

Subjects: “…leki generyczne, leki odtwórcze, generyk, generic drug, generics.…”
Get full text

The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies—An Empirical Study Based on the Difference-in-Differences Model by Yanyi Wei, Jialin Zhu, Jiahui Qiao, Dawei Zhang, Yuwen Chen, Yuwen Chen

Subjects: “…the consistent evaluation policy of generic drugs…”
Get full text

Impact of ‘4+7’ volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China by Jing Wang, ZongFu Mao, Yuan Shen, Ying Yang, Quan Wang, Dan Cui, Luxinyi Xu, Xiaotong Wen, Lining Mao

Get full text

Analiza nawyków i zachowań związanych ze stosowaniem leków oryginalnych i generycznych = The analysis of behaviour related to the use of original and generic drugs by Piotr Kozłowski, Dominika Streit, Magdalena Kozłowska

Subjects: Get full text

Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex by R. Navarro-Artieda, J. Rejas-Gutiérrez, M. Pérez-Paramo, A. Sicras-Mainar

“…Keywords: Neuropathic pain, Gabapentin, Brand name drugs, Generic drugs, Adherence, Costs, Age, Sex, Palabras clave: Dolor neuropático, Gabapentina, Medicamentos de marca, Genéricos, Adherencia, Costes, Edad, Género…”
Get full text

Simvastatin: between clinics and health economics by Francesco Vittorio Costa, Orietta Zaniolo

Subjects: Get full text

COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE by N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich

Subjects: Get full text

Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives by M Venkatesh, V G Bairavi, K C Sasikumar

Subjects: Get full text

Knowledge, attitude, and practice of generic medicines among physicians at multispecialty hospital: An observational study by Rajesh B Hadia, Dhaval B Joshi, Kushal H Gohel, Nikhil Khambhati

Subjects: Get full text

Analysis of antiviral efficacy after switching from brand to generic entecavir in patients with treatment-naïve chronic hepatitis B by Po-Ke Hsu, Pei-Yuan Su, Chia-Lin Wu

Subjects: Get full text